Cystic Fibrosis (CF) Therapeutics Market
Cystic Fibrosis (CF) Therapeutics Market Size, Share & Trends Analysis Report
Cystic Fibrosis (CF) Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Pancreatic Enzyme Supplements), By Route of Administration (Oral), By Distribution Channel, Based On Region, And Segment Forecasts, 2025 – 2031
Published
Report ID : BMRC 3386
Number of pages : 300
Published Date : Jun 2025
Category : Pharmaceutical
Delivery Timeline : 48 hrs
Key Players
- AbbVie Inc.
- F. Hoffmann-La Roche Ltd
- Gilead
- Novartis AG
- Vertex Pharmaceuticals Incorporated
- AIT (Advanced Inhalation Therapies)
- Alaxia
- Teva Pharmaceutical Industries Ltd.
- Merck & Co. Inc.
- Sionna Therapeutics
- Alcresta Therapeutics, Inc.
- AstraZeneca
Market Segmentations
Drug Class Outlook
- CFTR Modulators
- Pancreatic Enzyme Supplements
- Mucolytics
- Bronchodilators
Route of Administration Outlook
- Oral
- Inhaled
Distribution Channel Outlook
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
SUMMARY
Segments
Market Segmentations
Drug Class Outlook
- CFTR Modulators
- Pancreatic Enzyme Supplements
- Mucolytics
- Bronchodilators
Route of Administration Outlook
- Oral
- Inhaled
Distribution Channel Outlook
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
Key Players
- AbbVie Inc.
- F. Hoffmann-La Roche Ltd
- Gilead
- Novartis AG
- Vertex Pharmaceuticals Incorporated
- AIT (Advanced Inhalation Therapies)
- Alaxia
- Teva Pharmaceutical Industries Ltd.
- Merck & Co. Inc.
- Sionna Therapeutics
- Alcresta Therapeutics, Inc.
- AstraZeneca
